FBR Capital Upgrades Core Laboratories (CLB) to Outperform on 'Very Strong' Q4

January 31, 2013 8:56 AM

FBR Capital upgraded Core Laboratories (NYSE: CLB) from Market Perform to Outperform with a price target of $150.00 (from $110.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found